We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
-11.74%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$171M
AUM Growth
+$26.4M
Cap. Flow
+$3.79M
Cap. Flow %
2.21%
Top 10 Hldgs %
46.38%
Holding
55
New
23
Increased
12
Reduced
8
Closed
12

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.15M
2
EW icon
Edwards Lifesciences
EW
+$5.35M
3
ZBH icon
Zimmer Biomet
ZBH
+$5.16M
4
LLY icon
Eli Lilly
LLY
+$4.99M
5
ACRS icon
Aclaris Therapeutics
ACRS
+$3.53M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$8.8M
2
PHG icon
Philips
PHG
+$7.46M
3
CAH icon
Cardinal Health
CAH
+$4.7M
4
MEDP icon
Medpace
MEDP
+$3.46M
5
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 51.13%
2 Miscellaneous 44.03%
3 Industrials 3.39%
4 Financials 1.45%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
1
PUT
Acadia Pharmaceuticals
ACAD
$5.02B
$16.2M 9.48%
+563,200
New +$14.9M
QTNT
2
DELISTED
Quotient Limited Ordinary Shares
QTNT
$10.8M 6.32%
55,944
+1,302
+2% +$282K
SNY icon
3
PUT
Sanofi
SNY
$107B
$8.49M 4.95%
+210,000
New +$8.27M
CERN
4
PUT
DELISTED
Cerner Corp
CERN
$7.07M 4.12%
149,200
+89,200
+149% +$4.74M
GSK icon
5
GSK
GSK
$102B
$6.96M 4.06%
+144,649
New +$7.15M
GSK icon
6
CALL
GSK
GSK
$102B
$6.55M 3.82%
+136,000
New +$6.72M
PHG icon
7
Philips
PHG
$26.1B
$6.4M 3.74%
282,945
-341,907
-55% -$7.46M
HRC
8
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$5.98M 3.49%
106,594
+45,295
+74% +$2.57M
TRHC
9
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$5.81M 3.39%
388,054
-121,946
-24% -$1.56M
EW icon
10
Edwards Lifesciences
EW
$52B
$5.15M 3.01%
+165,000
New +$5.35M
CAH icon
11
PUT
Cardinal Health
CAH
$54.6B
$5.04M 2.94%
+70,000
New +$5.06M
CAH icon
12
Cardinal Health
CAH
$54.6B
$4.96M 2.89%
68,885
-65,052
-49% -$4.7M
LLY icon
13
Eli Lilly
LLY
$1.05T
$4.93M 2.88%
+67,000
New +$4.99M
ZBH icon
14
Zimmer Biomet
ZBH
$19.2B
$4.82M 2.81%
+48,125
New +$5.16M
WBA
15
PUT
DELISTED
Walgreens Boots Alliance
WBA
$4.72M 2.75%
+57,000
New +$4.71M
AMGN icon
16
PUT
Amgen
AMGN
$234B
$4.39M 2.56%
+30,000
New +$4.52M
ZTS icon
17
PUT
Zoetis
ZTS
$32B
$4.28M 2.5%
+80,000
New +$4.07M
AGN
18
PUT
DELISTED
Allergan plc
AGN
$4.2M 2.45%
+20,000
New +$4.14M
AAAP
19
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$4.1M 2.39%
153,332
+77,775
+103% +$2.61M
ACRS icon
20
Aclaris Therapeutics
ACRS
$885M
$3.76M 2.19%
+138,441
New +$3.53M
DMK
21
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$3.31M 1.93%
15,015
+5,508
+58% +$1.1M
NTUS
22
DELISTED
Natus Medical Inc
NTUS
$3.16M 1.84%
90,865
+34,865
+62% +$1.37M
PHG icon
23
CALL
Philips
PHG
$26.1B
$3.06M 1.78%
+135,056
New +$2.95M
RIGL icon
24
Rigel Pharmaceuticals
RIGL
$868M
$3.01M 1.75%
126,339
+24,267
+24% +$695K
AMGN icon
25
CALL
Amgen
AMGN
$234B
$2.92M 1.71%
20,000
-71,300
-78% -$10.7M
1
2 3

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sio Capital Management held 55 positions worth $171M, up 18% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management's Q4 2016 filing shows 23 new, 12 increased, 8 reduced and 12 closed positions. Its largest new stake was GSK: 144,649 shares worth $6.96M. The largest sale was Sanofi, an estimated $8.8M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Industrials.

  • Sio Capital Management's largest Q4 2016 buy was GSK: 144,649 shares worth $6.96M.
  • Sio Capital Management added most to Advanced Accelerator Applications S.A. in Q4 2016, an estimated $2.61M increase.
  • Sio Capital Management's biggest Q4 2016 reduction was Philips, cutting an estimated $7.46M.
  • Sio Capital Management fully exited Sanofi in Q4 2016, selling an estimated $8.8M.
  • Sio Capital Management's ten largest holdings make up 46% of its $171M portfolio in Q4 2016.
  • Sio Capital Management opened 23 new positions and closed 12 in Q4 2016.
  • Sio Capital Management's portfolio value rose 18% quarter-over-quarter to $171M.

Based on Sio Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.